SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $721,310 | +9.1% | 3,400 | -1.0% | 0.01% | +20.0% |
| Q2 2023 | $661,100 | +95022.3% | 3,435 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $695 | +55.5% | 3,435 | -1.2% | 0.01% | +25.0% |
| Q4 2022 | $447 | -100.0% | 3,475 | -78.1% | 0.00% | -77.8% |
| Q3 2022 | $2,169,000 | -19.7% | 15,875 | +4.0% | 0.02% | -25.0% |
| Q2 2022 | $2,702,000 | +22.9% | 15,269 | 0.0% | 0.02% | +60.0% |
| Q1 2022 | $2,199,000 | -14.9% | 15,269 | -20.5% | 0.02% | -21.1% |
| Q4 2021 | $2,585,000 | -29.2% | 19,215 | -10.7% | 0.02% | -13.6% |
| Q3 2021 | $3,653,000 | +158.9% | 21,514 | +140.7% | 0.02% | +144.4% |
| Q2 2021 | $1,411,000 | -63.8% | 8,939 | -68.1% | 0.01% | -64.0% |
| Q1 2021 | $3,893,000 | +31.2% | 28,039 | +65.5% | 0.02% | +31.6% |
| Q4 2020 | $2,967,000 | -14.8% | 16,939 | -4.8% | 0.02% | -32.1% |
| Q3 2020 | $3,483,000 | – | 17,799 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |